YaoGeJu

Company directoryChina company filings

Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd

As of 17 November 2026, for the company name Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd as recorded, 5 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 24 records, across 20 drug names; since 21 August 2026, the records list Marketing application approved: 2 applications, Accepted: 2 applications, No longer listed under review: 1 application; the chemical-drug catalogue lists 13 active records with this name as holder; 14 active API registrations list this name as first registered company; 3 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

24 acceptance records as first applicant, grouped into 20 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

醋酸地非法林注射液 · No verified English name 1 records · Latest accepted 2026/10/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602593Generic2026/10/22Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Edaravone and Dexborneol Concentrated Solution for Injection 1 records · Latest accepted 2026/09/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602418Generic2026/09/28Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Landiolol Hydrochloride for Injection 1 records · Latest accepted 2026/08/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602046Generic2026/08/18Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
注射用磷酸左奥硝唑酯二钠 · No verified English name 1 records · Latest accepted 2026/08/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601953Generic2026/08/10Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
注射用甲苯磺酸奥马环素 · No verified English name 1 records · Latest accepted 2025/06/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502238Generic2025/06/21Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Mupirocin Ointment 2 records · Latest accepted 2025/05/11

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501705Generic2025/05/11Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2404251Generic2024/12/07Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanizedCDE ↗
Cetrorelix Acetate for Injection 1 records · Latest accepted 2025/03/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501083Generic2025/03/15Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Oxytocin Injection 1 records · Latest accepted 2025/01/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500550Generic2025/01/28Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Crisaborole Ointment 1 records · Latest accepted 2024/12/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404142Generic2024/12/03Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Adapalene Gel 1 records · Latest accepted 2024/11/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404021Generic2024/11/23Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanizedCDE ↗
Potassium Phosphates Injection 1 records · Latest accepted 2024/03/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450199Supplement2024/03/16Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Yang Zhou Zhong Bao Pharma Co., Ltd. romanizedCDE ↗
Linaclotide Capsules 1 records · Latest accepted 2023/09/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302540Generic2023/09/20Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗
Carbetocin Injection 2 records · Latest accepted 2023/09/05

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301984Supplement2023/09/05Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
CYHB2250427Supplement2022/07/08Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
二甲双胍恩格列净片(I) · No verified English name 1 records · Latest accepted 2023/08/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302317Generic2023/08/30Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗
二甲双胍恩格列净片(V) · No verified English name 1 records · Latest accepted 2023/08/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302318Generic2023/08/30Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗
注射用BGC0222 · No verified English name 1 records · Latest accepted 2023/04/07

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHB2300083Supplement2023/04/07Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Lornoxicam for Injection 1 records · Latest accepted 2022/08/05

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250478Supplement2022/08/05Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Terlipressin for Injection 1 records · Latest accepted 2022/08/04

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250477Supplement2022/08/04Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Sitagliptin Phosphate Tablets 3 records · Latest accepted 2022/04/11

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200560Generic2022/04/11Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗
CYHS2200559Generic2022/04/11Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗
CYHS2200558Generic2022/04/11Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗
Thymalfasin for Injection 1 records · Latest accepted 2021/01/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2050816Supplement2021/01/01Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗

Changes in the last 90 days

5 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 2 applicationsAccepted: 2 applicationsNo longer listed under review: 1 application

  1. 2026/11/10Marketing application approved

    Mupirocin Ointment

    CYHS2501705 · 国药准字H20266580

    Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14

    View source · Table row 69 ↗
  2. 2026/11/03Marketing application approved

    Oxytocin Injection

    CYHS2500550 · 国药准字H20266441

    Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06

    View source · Table row 27 ↗
  3. 2026/10/29No longer listed under review

    Mupirocin Ointment

    CYHS2501705

    Fact date: 2026/10/29 · Date added to this site: 2026/10/29

    Accepted: 2025/05/11

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266580; approval date: 2026/11/10) · NMPA source · row 69

    NMPA · Table row 69 ↗ View source ↗
  4. 2026/10/22Accepted

    醋酸地非法林注射液 · No verified English name

    CYHS2602593

    Fact date: 2026/10/22 · Date added to this site: 2026/10/22

    View source ↗
  5. 2026/09/28Accepted

    Edaravone and Dexborneol Concentrated Solution for Injection

    CYHS2602418

    Fact date: 2026/09/28 · Date added to this site: 2026/10/21

    View source ↗

Under review

5 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
醋酸地非法林注射液 · No verified English name CYHS2602593Generic2026/10/22Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Edaravone and Dexborneol Concentrated Solution for Injection CYHS2602418Generic2026/09/28Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Landiolol Hydrochloride for Injection CYHS2602046Generic2026/08/18Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
注射用磷酸左奥硝唑酯二钠 · No verified English name CYHS2601953Generic2026/08/10Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Linaclotide Capsules CYHS2302540Generic2023/09/20Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanizedCDE ↗

Catalogue holder records

13 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Cetrorelix Acetate for InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H202657662026/08/25Generic approved under the new chemical-drug registration classificationCDE ↗
Potassium Phosphates InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdYang Zhou Zhong Bao Pharma Co., Ltd. romanized国药准字H202580972025/06/03Drug that passed quality-and-efficacy consistency evaluationCDE ↗
二甲双胍恩格列净片(V) · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdJiangsu Fei Ma Pharma Co., Ltd. romanized国药准字H202493632024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
二甲双胍恩格列净片(I) · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdJiangsu Fei Ma Pharma Co., Ltd. romanized国药准字H202493622024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Sitagliptin Phosphate TabletsSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdJiangsu Fei Ma Pharma Co., Ltd. romanized国药准字H202439742024/06/11Not stated by sourceCDE ↗
Sitagliptin Phosphate TabletsSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdJiangsu Fei Ma Pharma Co., Ltd. romanized国药准字H202439752024/06/11Not stated by sourceCDE ↗
Sitagliptin Phosphate TabletsSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdJiangsu Fei Ma Pharma Co., Ltd. romanized国药准字H202439732024/06/11Generic approved under the new chemical-drug registration classificationCDE ↗
Lornoxicam for InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H201130802023/10/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Terlipressin for InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H202032022023/09/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Carbetocin InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H201933732023/07/17Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Thymalfasin for InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H201032012022/01/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Octreotide Acetate InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H201330912021/11/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Octreotide Acetate InjectionSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd国药准字H201330922021/11/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

14 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
醋酸地非法林 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20260000643I2026/09/01CDE ↗
醋酸兰瑞肽 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20240000866A2026/04/27CDE ↗
醋酸地加瑞克 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20240000771I2025/05/20CDE ↗
醋酸地非法林 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20240000239I2024/04/02CDE ↗
利那洛肽 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20230000696A2025/09/09CDE ↗
醋酸西曲瑞克 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20230000378A2024/12/07CDE ↗
司美格鲁肽 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20220001169I2023/01/09CDE ↗
利拉鲁肽 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20220000141I2022/09/13CDE ↗
缩宫素 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20210000758A2025/06/13CDE ↗
胸腺法新 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20190009471A—CDE ↗
胸腺五肽 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20190003367A2025/05/07CDE ↗
卡贝缩宫素 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20170000889A2024/01/25CDE ↗
醋酸去氨加压素 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20170000345A2024/03/15CDE ↗
醋酸曲普瑞林 · No verified English nameSuzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdY20170000344A2023/05/14CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

3 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Sugammadex Sodium Injection CYHS2201201Generic2022/08/01Shanghai Hui Lun Jiangsu Pharma Co., Ltd. romanized; Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Sugammadex Sodium Injection CYHS2201200Generic2022/08/01Shanghai Hui Lun Jiangsu Pharma Co., Ltd. romanized; Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗
Nicorandil for Injection CYHS2201022Generic2022/07/06Suzhou Te Rui Pharma Co., Ltd. romanized; Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., LtdCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.